NeoKardio
NeoKardio
Every year, far more people reach end-stage heart failure than there are donor hearts to transplant. NeoKardio is developing a durable total artificial heart designed to restore circulation — and give patients their time back.
Heart failure care has advanced for decades, but a failing heart still needs a replacement — and there will never be enough donors. A total artificial heart changes the math.
Transplant depends on a donor heart arriving in time, matched, and viable. Most patients never get that call. An artificial heart removes the dependency on donor availability entirely.
NeoKardio is engineered to restore full circulation, not just bridge a patient in an ICU bed — with the goal of returning people to their families, their work, and their lives.
Developed with the regulatory and clinical-trial pathway in view from day one: quality systems, preclinical evidence, and a site strategy designed to withstand diligence.
Whether you treat patients or fund breakthroughs, the program is open now to the people who can move it forward.
For surgeons, cardiologists, transplant centers, and investigators who want a seat at the table as the program approaches the clinic.
For capital partners who back hard science with long horizons and want exposure to a platform-scale medical device thesis.
Tell us who you are and how you'd like to engage. A member of the NeoKardio team will follow up directly — typically within two business days.
Your inquiry is with the NeoKardio team. We'll follow up at the email you provided, usually within two business days.